Balloon-expandable transcatheter aortic valve replacement outcomes by procedure location: Catheterization laboratory versus operating room
Highlights
- • Balloon-expandable TAVR is safe in either procedure location - cath lab or hybrid OR.
- • No difference in procedural and 30-day outcomes between room types
- • Rates of open conversion are minimal for patients of all risk levels.
- • No difference in 30-day mortality in patients of all risk levels post-conversion
- • Balloon-expandable TAVR may be performed in the cath lab to optimize efficiency.
Abstract
Background
The impact of procedure location on clinical outcomes after TAVR remains unclear. We aimed to compare short-term outcomes in patients undergoing transcatheter aortic valve replacement (TAVR) in the catheterization laboratory (CATH) versus surgical operating room (OR).